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The chromosomal abnormalities of number and structure or 
the 22q11.2 and 10p13-14 microdeletions are considered 
the main causes of congenital heart disease. In our 
best knowledge, cytogenetics studies on congenital heart 
diseases (CHD) have not been performed in Algeria. In 
this study, we will screen for chromosomal abnormalities 
and microdeletions of 22q11.2 and 10p13 in a cohort of 
Algerian patients. G-banded by trypsin Giemsa (GTG) and 
Fluorescent In Situ Hybridization (FISH) techniques have 
been performed to screen for chromosomal abnormalities 
and a critical regions 22q11.2 and 10p13-14 respectively 
in seventy patients with non syndromic congenital heart. 
GTG technique visualized no chromosomal abnormalities 
of number and structure in our patients. Moreover, 
FISH visualizing critical regions 22q11.2 and 10p13-
14 respectively did not detect any microdeletion in the 
chromosomes 10 and 22 respectively of our patients. 
Our study could suggest that congenital heart defects 
observed in Algerian patients are not due to chromosomal 
abnormalities of number and structure nor the 22q11.2 
and 10p13-14 microdeletions. For the fist time, we report 
here cytogenetics analysis of chromosomal abnormalities 
and the 22q11.2 and 10p13-14 microdeletions in Algerian 
patients with congenital heart disease. Genetic testing 
for screening for deletion 22q11.2 and 10p13-14 is not 
indicated in all patients with isolated conotruncal defects. In 
addition, conotruncal heart diseases have a multifactorial 
background like consanguinity and recessive mutations in 
some genes involved in cardiac morphogenesis. A genetic 
study to screen for the role of consanguineous marriages 
and some genes linked to CHD in Algerian population is 
on going. This study will focus also on health education 
for the families at risk about the importance of pre-marital 
genetic counseling.
Key words: Algeria, ñonotruncal heart defects, FISH, chro-
mosomal abnormalities, 22q11 microdeletion, 10p13-14 micro-
deletion. 
Introduction. Congenital heart disease (CHD) is 
the most common birth defect and affects nearly 
6 ‰ [1] of newborns and the aetiology of CHD is 
largely unknown. Chromosomal imbalances have
been identified in many forms of syndromic CHD 
[2]. Di George syndrome (DGS) (thymus apla-
sia, hypoparathyroidism, facial dysmorphies and 
conotruncal anomalies) [3], velocardiofacial syn-
drome (VCFS) (cleft palate, learning disabili-
ties, cardiac malformations) [4] and conotruncal 
anomaly face syndrome (CTAFS) (hypertelorism, 
short palpebral fissures, nasal voice, mild mental 
retardation and conotruncal cardiac anomalies) [5] 
are commonly associated with conotruncal heart 
defects (CHD) characterized by abnormalities of 
the ventricular outflow tracts and aortic arch. These 
heart deficiencies include lesions such as tetralogy of 
Fallot, pulmonary atresia, ventricular septal defect 
interrupted aortic arch type B (IAA) and truncus ar-
teriosus (TA) [6]. Microdeletions of chromosomal 
region 22q11.2 are actually more considered as a 
principal cause of Di George syndrome [7, 8], velo-
cardiofacial syndrome [9] and conotruncal anomaly 
face syndrome [10, 11]. The haploinsufficiency of 
22q11 has been found also in some familial cases of 
heart disease [8, 12] and in sporadic patients with 
isolated CHD [13–17]. 
Few cases of DGS and VCFS were associated 
with a microdeletion 10p13-14 [18]. This micro-
deletion has been also reported in other clinical 
features with staturoponderal and psychomotor 
retardations, facial dysmorphism, urinary tract 
abnormalities, small ears and cardiac conotruncal 
anomalies [19, 20].  
We propose the following hypothesis that 
conotruncal isolated congenital heart defects could 
be caused by microdeletion 22q11.2 and 10q13-14 
or chromosomal abnormalities in Algerian patients. 
The aim of our study is genetic analysis by using 
fluorescent metaphasic chromosomes in situ hy-
bridisation to screen for the microdeletion 22q11 
(DGS1) and microdeletion 10p13 (DGS2) in Alge-
rian patients with sporadic and isolated conotruncal 
cardiac malformations.
Material and methods. Patients. Seventy patients, 
31 males and 39 females (ranging age from 1 to 28 
years) were included in the study. All patients were 
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referred from the cardiology center and pediatrics 
cardiology center of University hospitals in Algiers. 
Cardiac malformations diagnosis was confirmed by 
echocardiography, by cardiac catheterization in all 
the cases studied and 95 % of patients underwent 
surgical intervention. The patients were enrolled 
during their annual check in health control after 
their heart surgery. Most of cardiac anomalies de-
tected in our patients were tetralogy of fallot, iso-
late or associated, interventricular communication 
isolated alone or associated and other cardiopathies 
(Table 1). For all analyzed patients, the thymus 
was present, T-lymphocytes counts and the calce-
mia were normal. During the clinic visit, a clinical 
survey was conducted and the family history was 
negative for the presence of the conotruncal heart 
disease in our patients. The staturoponderal retar-
dation (25 %) was only one extracardiac anomaly. 
The cardiac anomalies or the live conditions are 
probably the cause of this clinical anomaly.
Table 1. Main clinical on the 70 patients
Patient Gender Age (years)
Congenital 
heart defect
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
M
M
F
M
F
M
F
M
F
F
F
M
F
F
M
F
M
F
F
F
F
M
F
F
F
F
M
F
F
F
M
M
F
M
M
10
11
17
18
16
12
18
 7
13
16
 3
13
18
15
12
16
15
10
18
 4
18
15
17
10
 4
13
 3
 4
 7
12
 6
 1
 8
 2
12
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF
TOF/PA
TOF/PA
TOF/AS
TOF/PA
TOF/PA
VSD
VSD
VSD
VSD
VSD
VSD
VSD
VSD
Patient Gender Age (years)
Congenital 
heart defect
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
M
M
F
F
M
M
M
F
F
M
F
F
M
F
F
M
F
F
M
M
M
F
F
M
F
F
M
F
M
F
M
M
F
F
M
14
 4
18
 3
 2
11
 8
15
13
 6
 9
 5
 8
 1
10
 7
12
15
24
22
 4
12
16
28
 4
11
11
17
 8
10
12
 5
 6
13
VSD
VSD
VSD
VSD
VSD
VSD
VSD
VSD/ASD
VSD/ASD
VSD/PA
VSD/PA
VSD/PA
VSD/PA
PA
PA
PA
PA
ASD
ASD
ASD
ASD
TGA
TGA
TGV
TGV
COA
COA
COA
COA
COA
COA
TA
TA
AS
AS
Note. M – male; F – female; TOF – tetralogy of Fallot; PA – pulmonary atresia; VSD – ventricular septal defect; 
ASD – atrial septal defect; TGA – transposition of the great arteries; COA – coartation of the aorta; TA – truncus 
arterious; AS – aortic stenosis.
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GTG technique. Chromosomes were prepared 
from phytohemaglutinin (PHA) stimulated periph-
eral lymphocytes, using standard techniques for a 
trypsine giemsa banding (GTG band).
FISH analysis. The probes provided by Scam-
bler were used for FISH on G0-G1 interphase nu-
clei and on metaphsic chromosomes spreads. The 
DO832 and SD10P1 which map the Di George 
crucial region (respectively 22q11.2 and 10p13-14) 
were combined with DAC9 chromosome 22 control 
probe and D10Z1 chromosome 10 control probe. 
The probes were labelled with digoxigenin, biotin 
or fluochrome by nick translation. Slides were pre-
treated with RNAse for 1 hour at 37 ºC, dehydrated 
in series of ethanol baths (75, 90, 100 %), denatured 
for 5 min at 75 ºC in 70 % formamide and newly 
re-dehydrated in series of cold ethanol baths (75, 
90, 100 %). The probes were also denatured at 75 ºC 
and put in contact with on denatured chromosomes 
slides for in situ hybridisation. After overnight hy-
bridization at 37 ºC in a moist chamber, the slides 
were washed and incubated with anti-digoxigenin 
fluorescein and anti-biotin antibodies at 37 ºC for 
30 min. The slides were mounted with antifade so-
lution. To visualize the fluorescence signals on the 
chromosomes, a cytovision probe fluorescence mi-
croscope equipped with an appropriate fluorescence 
filter sets was chosen. For detecting hemizygoty on 
22q11 and 10p13-14, at least 20 metaphases and 
10 nuclei were analysed with each probe for each 
patient.  
Results. A detailed list of the congenital heart de-
fects detected in our patients is shown on (Table 1).
Tetralogy of Fallot isolated (31,5 %) or associated 
(7,1 %), ventricular septal defect isolated (21,5 %) 
or additional cardiac anomalies (8,5 %) are the 
most frequent form of congenital heart diseases. 
Chromosomes were apparently normal by stan-
dard technique (400 band levels) in all analysed 
metaphases. Fluorescent hybridization analysis has 
showed two hybridisation signals on chromosomes 
22 with probe DO832 and on chromosomes 10 
with probe DZ10P, among in all analyzed patients 
(Figure).  
Discussion. The progress of molecular biology 
and more particularly application of FISH are in 
favour of a number more and more growing by cy-
togenetic abnormalities at children having a conge-
nital heart disorder. Different chromosomal modi-
fications such copying 1p34.1-34.2, 9p13ĺ9pter, 
19q13ĺ19qter, microdeletions 6q22.1-23.2, 8p23.1,
9q34.3, 15q21-22.2, 16 q21-22, 19p13ĺ pter and 
others are involved in syndromic congenital heart 
disorders but also in isolated CHD [21]. However, 
after the trisomy 21, the microdeletion 22q11.2 
remains the most frequent second chromosomal 
Fluorescent in situ hybridization preparation of metaphase cells (a) and nuclei (b, c) from a patient with cono-
troncal cardiac anomalies: VSD/ASD. The normal chromosomes 22 and 10 had 4 signals representing respectively 
the DO832 and SD10P1 which map the Di George crucial, the DAC9 chromosome 22 control probe and D10Z1 
chromosome 10 control probe
Table 2. Comparison of the proportion of marriage 
consanguine in the CDH and in the general population  
Index
CDH 
group
Gene-
ral 
popu-
lation, %
Ȥ2 P
Marriage First 
cousins 
Marriage Con-
sanguineous 
(Other lien)
Total 
32,8 % 
(23/70)
14,2 % 
(10/70)
47 % 
(33/70)
22
11,3
33,3
4,808
0,6225
6,039
0,028 (S)
0,430 (NS)
0,014 (S)
Note. S – significant; NS – not significant.
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abnormality detected in child’s congenital heart 
disorders. The majority of the bearing patients of 
the syndrome of Di George (70–90 %) or of the 
syndrome VCF introduce a microdeletion of identical 
size about 3 Mb in the region 22q11.2 [8, 22]. This 
last is also linked to strongly variable phenotypes 
defined by different cardiac insulated pathologies 
such as transposition of the great arteries [23], te-
tralogy of Fallot [24], and pulmonary atresia [25]. 
However, according to different reports the propor-
tion of congenital heart disorders not isolated lin-
ked with this microdeletion vary between 0.9–2 %
[26, 24] and 20–50 % [14]. The microdeletion re-
duced in 1,5 Mb doesn’t implicate an intermediate 
phenotype; the correlation genotype-phenotype is 
therefore difficult to establish [27].
The chromosomal abnormalities of number or 
of structure and microdeletions are absent in our 
patients with a congenital isolated heart disorder. 
Our results confirm the observations brought back 
by some authors concluding that congenital heart 
disorders isolated are hardly the consequence of 
microdeletion 22q11.2 [6, 12, 28, 29] or of micro-
deletion 10p13-14 [30].
The cardiac pathologies are hardly the prerogati-
ve to chromosome aberrations and of microdeletions. 
Indeed, the development of the molecular biology 
techniques allowed the identification of a number of 
genes involved in these pathologies and it also intro-
duces an important monogenic heterogeneity among 
these diseases. The absence of the transcription fac-
tor TBX1 which is encoded by a gene located in the 
critical region 22q11.2 appears to be responsible for 
cardiac defects [31]. The recessive mutations of the 
gene Nkx2.5 which encodes the transcription factor 
are detected in 3–4 % patients with various cardiac 
anomalies like the tetralogy of Fallot, the ventricular 
septal defect, the atrial septal defect and the tricuspid 
valve abnormality [32]. These results suggest that 
genes NKX2.5 and TBX1 play an important role in 
the development of cardiac structure. The mutations 
of the gene GATA4 encoding a transcription factor 
that interacts with the factor Nkx2.5 are involved 
in the ventricular septal defect and the atrial septal 
defect [33–35]. The mutation with incomplete pen-
etrance of the gene ZIC3 located on chromosome X 
is reported in patients with transposition of great ves-
sels [36]. Two CFC1 mutations are also detected in 
patients with transposition of great vessels or double 
outlet right ventricle [37].
The mutations in the gene that encodes the 
MYH6 myosin heavy chain 6 and the genes acti-
vated by TBX5 and GATA4 are detected in ob-
viousness in interauricular communications [38]. 
The mutations of genes CRELD1, ALK2, BMPR2, 
Notch1 [39, 40, 41] and PROSIT 240 [42] have 
been identified in the different cardiac pathologies.
All these data show the complex molecular ways 
involved in the cardiac morphogenesis and the im-
portance of some genes mutations in the genesis of 
the non-syndromic cardiac pathology. These mu-
tations can be dominant autosomal in variable 
entrance, recessive autosomal or linked to the X 
chromosome.
It is no more to show that as consanguinity in-
creases risks of pathologies appearance linked to gene 
mutations and more particularly to autosomal reces-
sive mutations [43]. Interestingly, our present study 
showed a significant correlation between consanguin-
ity and congenital heart disorders (P = 0,014). These 
results are in agreement with results reported Saudi 
Arabia [44], in Lebanon, [45] or in India [46]. Our 
results are emphasize the important role played by the 
segregation of recessive genes in the offspring in the 
etiology of CHD, there is an urgent need to educate 
the public about the deleterious effects of inbreeding, 
particularly in Algeria as in Arab populations, where 
the ratio of consanguineous marriage is very high. 
Gene mutations and more particularly the recessive 
mutations in some genes involved in cardiac mor-
phogenis could be at the origin of congenital non-
syndromic heart disorders in our Algerian patients. 
Classical studies showed that congenital consid-
ered as multifactorial heart disorders are due at the 
same time to gene mutations and to environmental 
influence [47]. The supplementation of folates at the 
mother during periconceptionnel period is known 
to reduce considerably the impact of the anomalies 
of the neural tube responsible for anomalies of the 
conotroncal trunk to the embryo [48, 49]. It is im-
portant to point out that an important proportion 
of the parents of our patients (21/70 : 30 %) live in 
disadvantageous conditions and are under feeding. 
These hard socioeconomic conditions also cause a 
maternal psychological and emotional effect which 
increases the risk of cardiac malformations [50].
Our present work aimed to screen for chromo-
somal abnormalities by using analysis of classical 
karyotype and Fluorescent Hybridization In Situ 
targeting the region 22q11.2 and 10p13-14 in Al-
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gerian patients. Our study showed the absence of 
these anomalies at all patients. But, interestingly 
according to molecular data reported on the dif-
ferent genes involved in the development of the 
conotroncal trunk, the screening of the germline 
mutations in some genes linked to CHD in Algerian 
patients in the near future will shed the light on the 
molecular genetics basis of this disease in Algerian 
population.
Conclusion. The screening of chromosomal ab-
normalities or microdeletions is not indicated in all 
patients with conotruncal heart defects. The main 
causes of this disease involve several biological and 
environmental factors and especially germline mu-
tations in some genes involved in cardiac morpho-
genesis. In addition, in Algeria, the high percentage 
of consanguineous marriage requires genetic coun-
seling   in order to prevent these heart problems in 
the families at risk. The consanguineous marriage 
should be discouraged through health education of 
the public.
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ÀÍÎÌÀËÈÉ È ÌÈÊÐÎÄÅËÅÖÈÉ 22q11 
È 10p13 Ó ÀËÆÈÐÑÊÈÕ ÏÀÖÈÅÍÒÎÂ 
Ñ ÈÇÎËÈÐÎÂÀÍÍÛÌÈ 
ÊÎÍÎÒÐÓÍÊÀËÜÍÛÌÈ ÀÍÎÌÀËÈßÌÈ 
F. Ammar-Khodja, M. Abdellali 
Õðîìîñîìíûå àíîìàëèè ÷èñëà è ñòðóêòóðû èëè 
ìèêðîäåëåöèè 22q11.2 è 10p13-14 ñ÷èòàþòñÿ ãëàâ-
íûìè ïðè÷èíàìè âðîæäåííîãî ïîðîêà ñåðäöà. Íà-
ñêîëüêî íàì èçâåñòíî, öèòîãåíåòè÷åñêèå èññëåäî-
âàíèÿ âðîæäåííîãî ïîðîêà ñåðäöà (CHD) â Àëæèðå
íå ïðîâîäèëèñü. Â íàñòîÿùåé ðàáîòå ïðîâåäåí ñêðè-
íèíã õðîìîñîìíûõ àíîìàëèé è ìèêðîäåëåöèé 
22q11.2 è 10p13-14 â ãðóïïå àëæèðñêèõ ïàöèåíòîâ. 
Ìåòîäû îêðàñêè ïî Ãèìçà (GTG) è FISH áûëè 
èñïîëüçîâàíû äëÿ ñêðèíèíãà õðîìîñîìíûõ àíîìà-
ëèé è êðèòè÷íûõ ó÷àñòêîâ 22q11.2 è 10p13-14 ñî-
îòâåòñòâåííî ó 70 ïàöèåíòîâ ñ íåñèíäðîìíûì âðîæ-
äåííûì ïîðîêîì ñåðäöà. GTG íå âûÿâèëî õðîìî-
ñîìíûõ àíîìàëèé ïî ÷èñëó è ñòðóêòóðå. Áîëåå òîãî,
èçó÷åíèå ó÷àñòêîâ 22q11.2 è 10p13-14 íå ïîêàçà-
ëî íèêàêèõ ìèêðîäåëåöèé â õðîìîñîìàõ 10 è 22.
Íàøè èññëåäîâàíèÿ ïîçâîëÿþò ñäåëàòü âûâîä, ÷òî
äåôåêòû, âûçâàííûå âðîæäåííûì ïîðîêîì ñåðäöà
ó àëæèðñêèõ ïàöèåíòîâ, íå ñâÿçàíû íè ñ õðîìîñîì-
íûìè àíîìàëèÿìè ÷èñëà è ñòðóêòóðû, íè ñ ìèêðî-
äåëåöèÿìè 22q11.2 è 10p13-14. Âïåðâûå ïðîâåäåí 
öèòîãåíåòè÷åñêèé àíàëèç õðîìîñîìíûõ àíîìàëèé 
è ìèêðîäåëåöèé 22q11.2 è 10p13-14 ó àëæèðñêèõ 
ïàöèåíòîâ ñ âðîæäåííûì ïîðîêîì ñåðäöà. Ãåíåòè-
÷åñêîå òåñòèðîâàíèå ñêðèíèíãà íà íàëè÷èå äåëå-
öèé 22q11.2 è 10p13-14 íå ïîêàçàíî ó âñåõ ïàöè-
åíòîâ ñ âðîæäåííûì ïîðîêîì ñåðäöà. Êðîìå òîãî,
êîíîòðóíêàëüíûå áîëåçíè ñåðäöà èìåþò ìíîãîôàê-
òîðíóþ îñíîâó, òàêóþ êàê ãåíåòè÷åñêîå ðîäñòâî è
ðåöåññèâíûå ìóòàöèè íåêîòîðûõ ãåíîâ, âîâëå÷åííûõ 
â êàðäèàëüíûé ìîðôîãåíåç. Ïðîâîäèòñÿ ãåíåòè÷åñ-
êîå èññëåäîâàíèå ðîëè áëèçêîðîäñòâåííûõ áðàêîâ è 
íåêîòîðûõ ãåíîâ, ñâÿçàííûõ ñ âðîæäåííûì ïîðîêîì 
ñåðäöà, â àëæèðñêîé ïîïóëÿöèè. Ýòî èññëåäîâàíèå 
áóäåò òàêæå ñôîêóñèðîâàíî íà ïðîôèëàêòè÷åñêîé 
ðàáîòå â ñåìüÿõ ñ ôàêòîðàìè ðèñêà è íà âàæíîñòè 
ãåíåòè÷åñêîãî êîíñóëüòèðîâàíèÿ ïåðåä âñòóïëåíèåì 
â áðàê.
ABBREVIATIONS
C HD    – conotruncal heart diseases
Di George syndrome
velocardiofacial syndrome
conotruncal anomaly face syndrome
interrupted aortic arch type B
truncus arteriosus
DGS    –
VCFS   –
CTAFS –
IAA      –
TA       –
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